Join to View Full Profile
Rabb 440Beth Israel Deaconess Medical CenterBoston, MA 02215
Phone+1 617-667-3739
Fax+1 617-667-2897
Dr. Wagner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- My practice at BIDMC focuses on treatment of kidney, prostate, bladder and testicular cancer. We provide multidisciplinary care for complicated GU cancer patients. We are also one of the few centers in New England providing a high volume of minimally invasive approaches to challenging urologic oncology procedures including robotic partial nephrectomy, robotic nerve-sparing prostatectomy, robotic radical cystectomy with orthotopic neobladder, and robotic RPLND. Our research interests vary from active surveillance of low grade prostate cancer and small renal masses, to HRQOL after GU cancer surgery, to investigating novel minimally invasive surgical approaches for GU cancer.
Education & Training
Johns Hopkins UniversityFellowship, Minimally Invasive Urologic Surgery, 2004 - 2006
UMass Chan Medical SchoolResidency, Urology, 2000 - 2004- UMass Chan Medical SchoolResidency, Surgery, 1998 - 2000
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1998
Certifications & Licensure
MA State Medical License 2006 - 2027
MD State Medical License 2004 - 2007
American Board of Urology Urology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
Publications & Presentations
PubMed
- Comprehensive characterization of the real-world perioperative morbidity of radical cystectomy in older adults.Boris Gershman, John Ernandez, Sumedh Kaul, Agustin Perez-Londono, Aaron Fleishman
Journal of Geriatric Oncology. 2025-07-01 - Long-term Outcomes and Prognostic Impact of Residual Cancer Burden After Intensified Neoadjuvant Therapy in High-risk Prostate Cancer.Praful Ravi, Lucia Kwak, Andres M Acosta, Saahil Rastogi, Wanling Xie
European Urology. 2025-06-01 - 2 citationsThe association of patient and disease characteristics with the overtreatment of low-risk prostate cancer from 2010 to 2016.Cooper Desmond, Sumedh Kaul, Aaron Fleishman, Ruslan Korets, Peter Chang
Prostate Cancer and Prostatic Diseases. 2025-06-01
Press Mentions
Beth Israel Deaconess Medical Center Expert Sources Available for Prostate Health MonthAugust 23rd, 2019
BIDMC’s Research & Health News Digest – June 2019 EditionJuly 1st, 2019
Teach Your Doctors WellOctober 26th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
